New! Make Your CRM Smarter with Best-In-Class Intent Data

Learn More!
Osmotica Pharmaceutical

Osmotica Pharmaceutical

Osmotica Pharmaceuticals plc (Nasdaq: OSMT) is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. RVL Pharmaceuticals, Inc. is the Company's ophthalmic subsidiary supporting UPNEEQ®. Vertical Pharmaceuticals, LLC represents the Company's diversified branded portfolio and Trigen Laboratories, LLC represents the Company's non-promoted products, including complex generic formulations. Osmotica has operations in the United States and Hungary.

Last updated on

About Osmotica Pharmaceutical

Founded

2000

Estimated Revenue

$100M-$250M

Employees

51-250

Funding / Mkt. Cap

$100M

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

SIC Code

28

NAICs Code

62151

Location

City

Bridgewater

State

New Jersey

Country

United States

Tech Stack (47)

search